CHRISTINE YEDINAK: Open Payments
NPI 1285640748 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,769 in 13 payments from 7 companies in 2025. Trend: 2023 $3,474 · 2024 $321 · 2025 $12,769
Consulting: $7,173Speaker / faculty: $4,406Travel & lodging: $920Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 7 | $7,602 |
| Eton Pharmaceuticals, Inc. | 1 | $2,243 |
| Ascendis Pharma Endocrinology Inc | 1 | $1,575 |
| Novo Nordisk Inc | 1 | $1,155 |
| Neurocrine BioSciences, Inc. | 1 | $82 |
| KYOWA KIRIN, INC. | 1 | $74 |
| Corcept Therapeutics | 1 | $39 |
Products named: MYCAPSSA, ALKINDI, Skytrofa, CRENESSITY, CRYSVITA, Korlym.
Industry payments across OR — which companies pay providers there.
